发明申请
US20060030713A1 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
失效
N-苯基芳基磺酰胺化合物,包含该化合物作为活性成分的药物组合物,该化合物的合成中间体及其制备方法
- 专利标题: N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
- 专利标题(中): N-苯基芳基磺酰胺化合物,包含该化合物作为活性成分的药物组合物,该化合物的合成中间体及其制备方法
-
申请号: US11239406申请日: 2005-09-30
-
公开(公告)号: US20060030713A1公开(公告)日: 2006-02-09
- 发明人: Atsushi Naganawa , Tetsuji Saito , Kaoru Kobayashi , Takayuki Maruyama , Yoshihiko Nakai , Shinsuke Hashimoto
- 申请人: Atsushi Naganawa , Tetsuji Saito , Kaoru Kobayashi , Takayuki Maruyama , Yoshihiko Nakai , Shinsuke Hashimoto
- 专利权人: ONO PHARMACEUTICAL CO., LTD.
- 当前专利权人: ONO PHARMACEUTICAL CO., LTD.
- 优先权: JPP.2001-68498 20010312; JPP.2001-281569 20010917; JPP.2002-7760 20020116
- 主分类号: A61K31/44
- IPC分类号: A61K31/44 ; C07C309/28 ; C07D277/36 ; C07D285/18
摘要:
An N-phenylarylsulfonylamide compound of formula (I) (R1 is COOH etc.; R2 is hydrogen, methyl, etc.; R3 and R4 are a combination of methyl and methyl, etc.; R5 is isopropyl etc.; Ar is thiazolyl, pyridyl, 5-methyl-2-furyl each optionally substituted with methyl; n is zero or 1), a synthetic intermediate for the compound and a process for its preparation. The compound of formula (I) binds to a prostaglandin E2 receptor, especially an EP1 subtype receptor, and antagonizes it. It is less affected by protein binding, so it has a satisfactory in vivo activity. Therefore, it is considered to be useful as an analgesic, an antipyretic agent, an agent for the treatment of pollakiuria (frequent urination) and/or lower urinary tract disease syndrome or an antineoplastic agent.